Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer LJ Ehteshami Bejnordi B, Veta M, Johannes van Diest P, van Ginneken B ... JAMA. 318 (22), 2199-2210, 2017 | 3042 | 2017 |
Predicting breast tumor proliferation from whole-slide images: the TUPAC16 challenge M Veta, YJ Heng, N Stathonikos, BE Bejnordi, F Beca, T Wollmann, ... Medical image analysis 54, 111-121, 2019 | 297 | 2019 |
Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4 X Dai, W Gan, X Li, S Wang, W Zhang, L Huang, S Liu, Q Zhong, J Guo, ... Nature medicine 23 (9), 1063-1071, 2017 | 291 | 2017 |
Immune escape in breast cancer during in situ to invasive carcinoma transition CRG Del Alcazar, SJ Huh, MB Ekram, A Trinh, LL Liu, F Beca, X Zi, ... Cancer Discovery 7 (10), 1098-1115, 2017 | 226* | 2017 |
Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types FF de Beça, P Caetano, R Gerhard, CA Alvarenga, M Gomes, J Paredes, ... Journal of clinical pathology 66 (3), 187-191, 2013 | 191 | 2013 |
Intratumor Heterogeneity in Breast Cancer F Beca, K Polyak Novel Biomarkers in the Continuum of Breast Cancer, 169-189, 2016 | 183 | 2016 |
Aspirin suppresses growth in PI3K-mutant breast cancer by activating AMPK and inhibiting mTORC1 signaling WS Henry, T Laszewski, T Tsang, F Beca, AH Beck, SS McAllister, ... Cancer Research 77 (3), 790-801, 2017 | 114 | 2017 |
SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression J Zhang, M Chen, Y Zhu, X Dai, F Dang, J Ren, S Ren, YV Shulga, F Beca, ... Developmental cell 48 (3), 329-344. e5, 2019 | 67 | 2019 |
Molecular analysis of TCGA breast cancer histologic types A Thennavan, F Beca, Y Xia, S Garcia-Recio, K Allison, LC Collins, ... Cell genomics 1 (3), 2021 | 63 | 2021 |
EN1 is a transcriptional dependency in triple-negative breast cancer associated with brain metastasis G Peluffo, A Subedee, NW Harper, N Kingston, B Jovanović, F Flores, ... Cancer research 79 (16), 4173-4183, 2019 | 55 | 2019 |
Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: Key events in the progression from an in situ to an invasive breast carcinoma D Martins, FF Beça, B Sousa, F Baltazar, J Paredes, F Schmitt Cell Cycle 12 (16), 2013 | 52 | 2013 |
LINC00520 is induced by Src, STAT3, and PI3K and plays a functional role in breast cancer. TA Henry WS, Hendrickson DG, Beca F, Glass B, Lindahl-Allen M, He L, Ji Z ... Oncotarget, 2016 | 42 | 2016 |
EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses’ Health Studies BAH Beca F, Kensler K, Glass B, Schnitt SJ, Tamimi RM Breast Cancer Research 19 (1), 21, 2017 | 40* | 2017 |
Altered PPP2R2A and Cyclin D1 expression defines a subgroup of aggressive luminal-like breast cancer F Beca, M Pereira, JF Cameselle-Teijeiro, D Martins, F Schmitt BMC cancer 15, 1-10, 2015 | 37 | 2015 |
The genomic landscape of metastatic histologic special types of invasive breast cancer F Pareja, L Ferrando, SSK Lee, F Beca, P Selenica, DN Brown, ... NPJ Breast Cancer 6 (1), 53, 2020 | 30 | 2020 |
Genotypes and prevalence of HPV single and multiple concurrent infections in women with HSIL F Beca, J Pinheiro, E Rios, P Pontes, I Amendoeira Diagnostic cytopathology 42 (11), 919-923, 2014 | 29 | 2014 |
Improved malignancy prediction by B3 breast lesions subclassification FF de Beça, C Rasteiro, A Correia, S Costa, I Amendoeira Annals of diagnostic pathology 17 (5), 434-436, 2013 | 26 | 2013 |
Ancillary Tests in Breast Cytology: A Practical Guide F Beca, FC Schmitt Acta cytologica 63 (4), 302-313, 2019 | 24 | 2019 |
Androgen receptor expression in normal breast tissue and subsequent breast cancer risk KH Kensler, F Beca, GM Baker, YJ Heng, AH Beck, SJ Schnitt, A Hazra, ... NPJ Breast Cancer 4 (1), 33, 2018 | 24 | 2018 |
Growing indication for FNA to study and analyze tumor heterogeneity at metastatic sites F Beca, F Schmitt Cancer cytopathology 122 (7), 504-511, 2014 | 23 | 2014 |